76 related articles for article (PubMed ID: 3661335)
1. [Analgesic effect of calcitonin in patients with metastatic bone lesions from urogenital cancer].
Ohnishi K; Nakagawa S; Miyashita H; Itakura Y; Saito M; Ohe H; Watanabe H
Hinyokika Kiyo; 1987 May; 33(5):682-5. PubMed ID: 3661335
[TBL] [Abstract][Full Text] [Related]
2. [Experience of Elcitonin treatment in metastatic bony pain of urological tumors].
Tokunaka S; Fujii H; Okamura K; Hashimoto H; Fujisawa M; Miyata M; Arima S; Yachiku S
Hinyokika Kiyo; 1988 Jul; 34(7):1273-7. PubMed ID: 3177147
[TBL] [Abstract][Full Text] [Related]
3. [Effect of calcitonin on body pains caused by bone metastases of urogenital cancer].
Sugiyama T; Kohri K; Yachiku S; Kurita T
Hinyokika Kiyo; 1983 Aug; 29(8):953-8. PubMed ID: 6675446
[TBL] [Abstract][Full Text] [Related]
4. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
Kimura M; Abe R
Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
[TBL] [Abstract][Full Text] [Related]
5. [Eel calcitonin treatment on patients with urogenital carcinoma for relief of pain from metastatic bone lesions].
Noguchi K; Kubota Y; Moriyama M; Kinoshita Y; Hosaka M; Kondo I; Fukushima S; Fujii H; Miyai K; Satomi Y
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2577-86. PubMed ID: 2614193
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of eel calcitonin for relief of pain from metastatic bone lesions].
Sasaki F; Uchino J; Hata Y; Sato Y; Konno T; Okuno T; Ohira S; Taguchi K; Fuzisawa J; Oku T
Gan To Kagaku Ryoho; 1991 Mar; 18(3):437-42. PubMed ID: 2003741
[TBL] [Abstract][Full Text] [Related]
7. [Effect of porcine calcitonin on pain caused by cancer-induced bone destruction].
Egawa J; Kawada Y; Abe M; Miki H; Fujinuma A; Utsunomia Y; Kawano H; Kawaguchi H; Kuroiwa S; Saito A
Gan No Rinsho; 1984 Mar; 30(3):251-8. PubMed ID: 6716657
[TBL] [Abstract][Full Text] [Related]
8. [Salmon calcitonin in metastatic bone pain. Demonstration of acute analgesia in tumor patients].
Kleibel F; Schmidt G
Dtsch Med Wochenschr; 1984 Jun; 109(24):944-7. PubMed ID: 6376042
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of a synthetic calcitonin derivative (elcatonin) in patients with metastatic bone tumors].
Okayasu T; Masuda T; Hashimoto M; Tanabe T
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2703-9. PubMed ID: 3631970
[TBL] [Abstract][Full Text] [Related]
10. An analgesic effect of synthetic human calcitonin in patients with primary osteoporosis.
Kapuściński P; Tałałaj M; Borowicz J; Marcinowska-Suchowierska E; Brzozowski R
Mater Med Pol; 1996; 28(3):83-6. PubMed ID: 9167417
[TBL] [Abstract][Full Text] [Related]
11. Characterization of bone metastases in patients with renal cell cancer.
Adiga GU; Dutcher JP; Larkin M; Garl S; Koo J
BJU Int; 2004 Jun; 93(9):1237-40. PubMed ID: 15180614
[TBL] [Abstract][Full Text] [Related]
12. [Anti-pain effect of salmon calcitonin in bone metastases of malignant tumors with the exception of breast and prostatic carcinoma].
Jelić S; Borkovacki R; Babović N; Kovcin V; Milanović N
Vojnosanit Pregl; 1995; 52(2):151-4. PubMed ID: 7571528
[TBL] [Abstract][Full Text] [Related]
13. [Effect of treatment with synthetic eel-calcitonin derivative in patients suffering pain due to bone metastases].
Takahashi K; Kikuchi Y; Nishino S; Asano A; Yoshikawa H; Amoh K; Uekita Y
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2004-10. PubMed ID: 4051517
[TBL] [Abstract][Full Text] [Related]
14. [20 cases of hypercalcemia associated with urogenital malignancies].
Higashi Y; Kawamura J; Kanamaru H; Kakehi Y; Yoshida O
Hinyokika Kiyo; 1984 May; 30(5):599-607. PubMed ID: 6475683
[TBL] [Abstract][Full Text] [Related]
15. Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.
Tsavaris N; Kopterides P; Kosmas C; Vadiaka M; Dimitrakopoulos A; Scopelitis H; Tenta R; Vaiopoulos G; Koufos C
Oncol Rep; 2006 Oct; 16(4):871-5. PubMed ID: 16969508
[TBL] [Abstract][Full Text] [Related]
16. Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
Kerst JM; Bex A; Mallo H; Dewit L; Haanen JB; Boogerd W; Teertstra HJ; de Gast GC
Cancer Immunol Immunother; 2005 Sep; 54(9):926-31. PubMed ID: 15906025
[TBL] [Abstract][Full Text] [Related]
17. Salmon calcitonin in cancer pain: comparison between two different treatment schedules.
Schiraldi GF; Soresi E; Locicero S; Harari S; Scoccia S
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):229-32. PubMed ID: 3583473
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of bone metastases from renal cell carcinoma].
Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
[TBL] [Abstract][Full Text] [Related]
19. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
Kylmälä T; Tammela TL; Lindholm TS; Seppänen J
Ann Chir Gynaecol; 1994; 83(4):316-9. PubMed ID: 7537482
[TBL] [Abstract][Full Text] [Related]
20. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
Strang P; Nilsson S; Brändstedt S; Sehlin J; Borghede G; Varenhorst E; Bandman U; Borck L; Englund G; Selin L
Anticancer Res; 1997; 17(6D):4717-21. PubMed ID: 9494595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
